{
  "id": 16161455,
  "title": "SK Bioscience Expands AI Adoption in Vaccine Manufacturing, Targets Company-Wide Digital Transformation",
  "url": "https://urgent.news/2026/10/23/sk-bioscience-expands-ai-adoption-in-vaccine-manufacturing-targets",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-23T07:24:51.000Z",
  "source": {
    "name": "Korea IT Times",
    "slug": "korea-it-times",
    "url": "https://www.koreaittimes.com/news/articleView.html?idxno=158459"
  },
  "original_language": "en",
  "account": "SK Bioscience is expanding its use of artificial intelligence across various vaccine operations as part of a comprehensive digital transformation initiative. The South Korean manufacturer presented its AI-driven manufacturing and digital transformation strategy at the AI Bio Drug Discovery Summit 2026 in Incheon. SK Bioscience's Head of AI Transformation Planning, Lee Yong, showcased the company's progress in deploying AI technologies in vaccine production and outlined plans to expand their use across business functions. The company has introduced an AI-powered Yield Guide Agent at its Andong manufacturing facility to optimize vaccine yields in fluctuating production conditions. This system analyzes manufacturing data to recommend operating conditions that could improve process efficiency while supporting rather than replacing human decision-making. SK Bioscience aims to use AI-assisted analysis to enhance operational efficiency and process stability. The company intends to expand AI adoption into research and development, clinical and regulatory operations, and quality management. Lee emphasized the importance of connecting data and knowledge across different functions to create an environment where people and AI can collaborate effectively. SK Bioscience is developing an enterprise-wide AI framework called AI Brain to connect business systems and information across research, manufacturing, and supply operations. The company plans to implement more comprehensive AI-driven initiatives beginning in 2029.",
  "summary": "SK Bioscience is accelerating the adoption of artificial intelligence across its vaccine operations, expanding from manufacturing process optimization to research and development, regulatory affairs and quality management as part of a broader company-wide AI transformation strategy.The South Korean vaccine manufacturer presented its AI-driven manufacturing initiatives and digital transformation…",
  "key_points": [
    "SK Bioscience expands AI use in vaccine manufacturing operations.",
    "AI-powered Yield Guide Agent optimizes yields at Andong facility.",
    "Company aims for AI Brain to connect data across all business functions."
  ],
  "editors_take": "Integrating artificial intelligence across research and manufacturing processes shifts the company toward an interconnected digital framework designed to enhance operational stability and support human decision-making through data-driven insights.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}